arrow
返回
T

Tuğçe Kübra Güneş

university of health sciences

2H指数
22论文数
19被引数
收录论文 9
发表时间
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab免疫相关不良事件作为接受帕博利珠单抗治疗的早期三阴性乳腺癌中病理完全缓解的预测因子
err2026-04-01
err1
PREAI
errGuren, Ali Kaan; Demircan, Nazim Can; Gumusay, Ozge; Simsek, Eda Tanrikulu; Kemik, Fatih; Karaoglu, Cagla; Sahin, Taha Koray; Tunbekici, Salih; Akkaya, Kubra; Guliyev, Murad; Gezici, Baris; Gur, Hasibe Bilge; Karakas, Delyadil; Unlu, Ahmet; Altunok, Oguz; Nazli, Ismail; Biter, Sedat; Kaya, Tugba; Yetginoglu, Ozge; Gunes, Tugce Kubra; Seker Can, Lamia; Majidova, Nargiz; Sever, Nadiye; Akkus, Aysun Fatma; Kara, Ismail Oguz; Ozturk, Banu; Deligonul, Adem; Kaplan, Muhammet Ali; Atag, Elif; Hacibekiroglu, Ilhan; Demirci, Nebi Serkan; Biricik, Fatih Selcuk; Guven, Deniz Can; Aksoy, Sercan; Arikan, Rukiye; Sari, Murat; Bayoglu, Ibrahim Vedat; Kostek, Osman
err分享
err收藏
Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study免疫检查点抑制剂在错配修复缺陷型结直肠癌患者中的疗效、安全性和生存结局:一项回顾性、多中心研究
err2026-02-27
err0
errOAAI
errMehmet Cihan İcli; Deniz Can Guven; Arif Akyildiz; Ali Fuat Gürbüz; Nargiz Majidova; Mehmet Mutlu Kıdı; Hakan Kosku; Elif Sahin; Tugce Kubra Gunes; Mustafa Seyyar; Elvina Almuradova; Pervin Can Sancı; Burak Bilgin; Ismail Oguz Kara; Mehmet Artac; Ömer Dizdar; Suayib Yalcin
err分享
err收藏
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Groupbrigatinib 在晚期ALK阳性NSCLC中的真实世界有效性与安全性:土耳其肿瘤学组进行的一项全国多中心研究
err2026-02-11
err0
PREAI
errSalih Tunbekici; Hamit Bal; Oguzcan Kınıkoglu; Hayati Arvas; Harun Muglu; Ahmet Bilici; Mustafa Seyyar; Halil Goksel Guzel; Banu Ozturk; Ozge Yalıcı; Duygu Ozaskın; Ramazan Cosar; Fatmagul Cıkladılmez; Evrican Zin; Aytac Terzi; Tugce Ulaslı; Taha Koray Sahın; Denız Can Guven; Gamze Serın; Merve Bıyıklı Alemdar; Bilgin Demir; Ali Kalem; Pervin Can; Kazım Uygun; Elif Sahin; Teoman Sakalar; Ali Kaan Guren; Gokhan Ozturk; Enes Yesılbas; Tugce Kubra Gunes; Burcu Belen; Muzaffer Ugraklı; Kursat Dıslı; Ahmet Oruc; Melek Karakurt Eryılmaz; Ismet Culcuoglu; Mustafa Ersoy; Bahadır Koylu; Fatih Selcukbiricik; Oguzhan Yıldız; Mehmet Emın Yılmaz; Saadettin Kılıckap; Ertugrul Bayram; Caner Acar; Gokhan Sahin; Haydar Cagatay Yuksel; Mustafa Murat Mıdık; Pınar Gursoy; Erdem Goker
err分享
err收藏
Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinomaIMDC评分参数对转移性透明细胞肾细胞癌患者的影响分析
err2025-11-01
err0
PREAI
errErciyestepe, Mert; Gunes, Tugce Kubra; Dinc, Gulhan; Akkaya, Kubra; Ozturk, Ahmet Emin; Aydin, Okan; Dinc Sonusen, Sermin; Celik, Emir; Erturk, Kayhan; Atci, Muhammed Mustafa
err分享
err收藏
Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group曲拉妥单抗(sacituzumab govitecan)在伴有转移性或局部晚期不可切除的三阴性乳腺癌患者中的真实世界有效性与安全性:土耳其肿瘤学组(Turkish Oncology Group)开展的一项多中心研究
err2025-10-28
err0
PREAI
errSalih Tunbekici; Gokhan Sahin; Sercan Ön; Ahmet Oruc; Melek Karakurt Eryılmaz; Abdullah Sakin; Alper Coskun; Mustafa Seyyar; Fatma Keskin Uzundere; Erdem Kolemen; Devrim Cabuk; Safa Can Efil; Teyfik Demir; Emine Turkmen; Ferhat Ekinci; Aytac Terzi; Taha Koray Sahin; Deniz Can Guven; Sercan Aksoy; Ali Aytac; Özge Demirkıran; Bilgin Demir; Ismet Culcuoglu; Mustafa Ersoy; Esra Asarkaya; Ufuk Camanlı; Barıs Gezici; Ahmet Ozveren; Alper Sevınc; Sait Kitaplı; Ahmet Unlu; Banu Ozturk; Alper Turkel; Mutlu Dogan; Ferit Aslan; Enes Yesilbas; Esmanur Kaplan; Teoman Sakalar; Elif Sahin; Gamze Emin; Esra Asık; Atilla Yıldırım; Taliha Guclu; Irem ugurlu; Fatma Kahvecioglu; Ilhan Hacıbekiroglu; Ibrahim Tunbekici; Selami Bayram; Ali Osman Kaya; Nargiz Majidova; Ozge Yalıcı; Murat Karateke; Nilufer Avcı; Burcu Belen; Hamit Bal; Oguzcan Kınıkoglu; Fatma Paksoy Turkoz; Eda Tanrıkulu Sımsek; Oguz Altınok; Tugce Kubra Gunes; Yunus Emre Altıntas; Murad Guliyev; Gokhan Ozturk; Dilek Erdem; Yakup Duzkopru; Ali Inal; Ali Kaan Guren; Nilgun Yıldırım; Tugba Akın Telli; Yurdagul Danacı; Umut Aydın; Elvina Almuradova; Hasan Cagrı Yıldırım; Pınar Gursoy; Mehmet Ali Nahit Sendur; Erdem Goker
err分享
err收藏
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group卡博替尼与舒尼替尼在晚期非透明细胞肾细胞癌中的真实世界比较:土耳其肿瘤学集团的多中心研究
err2025-09-01
err0
PREAI
errSahin, Gokhan; Tuzun, Esmanur Kaplan; Guzel, Halil G.; Guliyev, Murad; Disli, Ahmet K.; Yazici, Melike; Yildiz, Oguzhan; Gunes, Tugce K.; Alkan, Suleyman; Kahraman, Emir G.; Ozel, Gamze Serin; Icli, Mehmet C.; Sahin, Elif; Muglu, Harun; Acar, Caner; Tunbekici, Salih; Yuksel, Haydar C.; Yucel, Hakan; Kahya, Burcu Ulas; Kitapli, Sait; Buyuksimsek, Mahmut; Ipek, Suheda A.; Dama, Pinar E.; Usta, Ekin Akyildiz; Yilmaz, Mesut; Asik, Esra; Ozalp, Faruk R.; Savsar, Mehmet G.; Kocaaslan, Erkam; Sim, Saadet; Agaoglu, Ahmet B.; Camoz, Elif Sertesen; Demir, Teyfik; Uyar, Galip C.; Yildirim, Atila; Cinkir, Havva Y.; Salim, Derya Kivrak; Dogu, Gamze Gokoz; Alan, Ozkan; Bayram, Ertugrul; Karacin, Cengiz; Guc, Zeynep G.; Ekinci, Ferhat; Eryilmaz, Melek Karakurt; Semiz, Huseyin S.; Unal, Olcun U.; Goksu, Sema Sezgin; Ozturk, Banu; Inanc, Mevlude; Uygun, Kazim; Hacibekiroglu, Ilhan; Ercolak, Vehbi; Kara, Ismail O.; Yazici, Ozan; Bilici, Ahmet; Tanriverdi, Ozgur; Karaca, Burcak; Erman, Mustafa; Gokmen, Erhan; Goker, Erdem; Yildirim, Hasan Cagri
err分享
err收藏
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study比较mFOLFOX-6和mDCF方案在转移性胃癌治疗中的疗效:一项多中心回顾性研究
err2025-08-30
err0
errOAAI
errOgur Karhan; Serdar İleri; Zuhat Urakçı; Yasin Sezgin; Ümit Yıldırım; Beyza Ünlü; Hacer Demir; Hasibe Bilge Gür; Ayşe Demirci; Melih Şimşek; Hüseyin Salih Semiz; Savaş Gökçek; Nilgün Yıldırım; Tuğçe Kübra Güneş; Abdilkerim Oyman; Tolga Doğan; Gamze Gököz Doğu; Yusuf İlhan; Özgür Tanrıverdi; Ali İnal; Nadiye Sever; Ezgi Türkoğlu; Tugay Avcı; Sadi Kerem Okutur; Pınar Peker; Doğan Bayram; Onur Yazdan Balçık; Pervin Can Şancı; Seray Saray; Pınar Çoban Eşdur; İsmail Beypınar; Sezai Tunç
err分享
err收藏
Very Favorable vs. Favorable Risk Groups in Metastatic Renal Cell Carcinoma: A Step Toward Personalized Treatment在转移性肾细胞癌中,非常有利组与有利风险组的比较:个性化治疗的一步
errCANCERS
IF4.4
err2025-03-23
err0
errOAAI
errAltintas, Yunus Emre; Kinikoglu, Oguzcan; Isik, Deniz; Gunes, Tugce Kubra; Ozkerim, Ugur; Basoglu, Tugba; Surmeli, Heves; Odabas, Hatice; Turan, Nedim
err分享
err收藏